www.oncoic.orgwww.esoi-society.org

JUNE 28–30, 2018DUBROVNIK/HR

BEST PRACTICES AND FUTURE TRENDS IN CANCER IMAGING: OPTIMUM RESULTS

+ YOUNG RADIOLOGISTS’ SPECIAL SESSION JUNE 27, 2018

COURSE ORGANISERS AND FACULTY

Organisers R. Beets-Tan, Amsterdam/NLThe Netherlands Cancer Institute Ch. Herold, Vienna/ATMedical University Vienna H. Hricak, New York/USMemorial Sloan Kettering Cancer Center A. Laghi, Rome/ITUniversity of Rome „Sapienza“ - I.C.O.T. D. Regge, Turin/ITCandiolo Cancer Centre M. F. Reiser, Munich/DEUniversity Hospitals LMU-Munich

Programme CommitteeM. D‘Anastasi, Msida/MT Mater Dei HospitalM. Mayerhöfer, Vienna/AT Medical University ViennaD. Panicek, New York/US Memorial Sloan Kettering Cancer Center

FacultyP. Baltzer, Vienna/ATR. Barakat, New York/USA. Baur-Melnyk, Munich/DER. Beets-Tan, Amsterdam/NLM. von Bergwelt, Munich/DEB. Brkljačić, Zagreb/HRC. Comstock, New York/USC. Cyran, Munich/DEM. D‘Anastasi, Msida/MTM. Fuchsjäger, Graz/ATM. Ginsberg, New York/USM. Gollub, New York/USTh. Helbich, Vienna/ATCh. Herold, Vienna/ATH. Hricak, New York/USM. Jochelson, New York/USW. Kunz, Munich/DEA. Laghi, Rome/ITM. Mayerhöfer, Vienna/ATE. Morris, New York/USE. Neri, Pisa/IT

D. Panicek, New York/USK. Pinker-Domenig, Vienna/ATH. Prosch, Vienna/ATD. Regge, Turin/ITM. F. Reiser, Munich/DEJ. Ricke, Munich/DED. Tamandl, Vienna/ATA. Vargas, New York/US

Thank  you

PARTNERS

OIC.8 IS JOINTLY ORGANISED BY

OIC.8 IS KINDLY SPONSORED BY

PROGRAMME & PRESENTED ABSTRACTS

YOUNG RADIOLOGISTS’ SPECIAL SESSION

Imaging BiomarkersChairs: R. Beets-Tan, Amsterdam/NL

H. Hricak, New York/US

14:30 Welcome and introduction R. Beets-Tan, Amsterdam/NL

H. Hricak, New York/US

Imaging Biomarkers for Cancer Diagnosis

Invited Lecture14:40 Imaging biomarkers for cancer diagnosis D. Regge, Turin/IT

Presented Abstracts15:00 Multi-parametric Magnetic Resonance Imaging of

Prostate Cancer: Correlation Between ktrans, Gleason Score, and PI-RADS score T. Biondi, Belvedere Marittimo/IT

15:08 Role of diffusion tensor imaging in subtyping of breast cancer with breast MRI P. Clauser, Vienna/AT

15:16 A predictive multiparametric [18F]FDG-PET/MRI model including imaging biomarkers of the tumor and contra- lateral healthy breast tissue aids breast cancer diagnosis D. Leithner, New York/US

15:24 A novel open-access neural network for evaluation of suspicious masses detected in breast MRI for direct integration into clinical workflows S. Ellmann, Erlangen/DE

15:30 Discussion

15:45 30-minute coffee break

Imaging Biomarkers of Tumour Response

Invited Lecture16:15 Imaging biomarkers of tumour response A. Laghi, Rome/IT

Presented Abstracts16:35 A Computer-aided diagnosis (CAD) scheme for

pretreatment prediction of pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer patients using dynamic contrast- enhanced MRI texture features. V. M. Doronzio, Turin/IT

WEDJUNE 27, 2018

WEDJUNE 27, 2018PROGRAMME & PRESENTED ABSTRACTS

16:43 Comparison of RECIST, iRECIST, and PERCIST for the evaluation of response to PD1-blockage therapy in patients with non-small cell lung cancer L. Beer, Vienna/AT

16:51 CT Texture Analysis in assessing the response to neoadjuvant chemotherapy in Gastric Cancer: preliminary results of a multicenter GIRCG study G. Bagnacci, Siena/IT

16:59 Radiomics as a predictive biomarker of metastatic response to immunotherapy Z. Elkarghali, Amsterdam/NL

17:05 Discussion

Keynote Lecture

17:20 How to peer-review a scientific manuscript M. F. Reiser, Munich/DE

ESOI Survey Presentation

17:40 Involvement of radiologists in oncologic multidisciplinary teams E. Neri, Pisa/IT

17:55 Discussion

PROGRAMME

THUJUNE 28, 2018

SESSION 1

Essentials for Interpreting Oncologic Imaging ExaminationsChairs: H. Hricak, New York/US

D. Panicek, New York/US

08:15 Welcome and introduction R. Beets-Tan, Amsterdam/NL

Ch. Herold, Vienna/AT H. Hricak, New York/US M. F. Reiser, Munich/DE J. Ricke, Munich/DE

08:20 Language in reporting: Optimising your reports, and what to avoid

D. Panicek, New York/US08:40 Structured reporting in oncology: Pearls and pitfalls A. Vargas, New York/US09:00 Common errors in oncologic imaging D. Panicek, New York/US09:20 Panel discussion All speakers session 1

09:40 20-minute coffee break

SESSION 2

Thoracic OncologyChairs: Ch. Herold, Vienna/AT

H. Prosch, Vienna/AT

10:00 Pulmonary adenocarcinoma: New classification and implications for management

Ch. Herold, Vienna/AT10:20 Staging of lung cancer: Update on changes H. Prosch, Vienna/AT10:40 Complications in the treatment of thoracic tumours M. Ginsberg, New York/US 11:00 Chameleons in thoracic oncology

H. Prosch, Vienna/AT11:20 Post radiation therapy in lung imaging

M. Ginsberg, New York/US11:40 Interactive case discussions All speakers session 2

INDUSTRY SESSION

PET-MRI body applications 12:00 M. Goyen, Chief Medical Officer Europe (GE Healthcare)

12:15 75-minute lunch break

SESSION 3

GYN OncologyChairs: H. Hricak, New York/US

A. Vargas, New York/US

13:30 Imaging as GPS to surgical planning: A surgeon‘s point of view

R. Barakat, New York/US13:50 Imaging cancer of the endometrium and cervix –

addressing the key treatment questions H. Hricak, New York/US14:10 Imaging spectrum of peritoneal carcinomatosis and

mesenteric neoplasms: How the radiologist can help the treatment plan

A. Vargas, New York/US14:30 Interactive case discussions All speakers session 3

14:50 30-minute coffee break

SPECIAL LECTURE

15:20 Future of radiological response criteria in times of liquid biopsy

J. Ricke, Munich/DE

SESSION 4

GU OncologyChairs: C. Cyran, Munich/DE

A. Vargas, New York/US

15:40 Key elements in staging renal tumours before laparoscopic surgery

M. D‘Anastasi, Msida/MT16:00 Prostate MRI in 2018, who should have one and what

should we look for A. Vargas, New York/US16:20 Functional imaging of prostate cancer: Therapeutic

implications C. Cyran, Munich/DE 16:40 Interactive case discussions All speakers session 4

WORKSHOP 1 – HANDS-ON

Criteria-Based Reporting (RECIST) 17:00 M. D‘Anastasi, Msida/MT

W. Kunz, Munich/DE

PROGRAMME

THUJUNE 28, 2018

F R IJUNE 29, 2018PROGRAMME

SESSION 5

Gastrointestinal OncologyChairs: M. Gollub, New York/US

A. Laghi, Rome/IT

08:30 Rectal MRI for local staging prior to treatment: Pearls and pitfalls

M. Gollub, New York/US08:50 GIST – diagnosis and treatment response

assessment with imaging A. Laghi, Rome/IT09:10 Neuroendocrine tumours M. Mayerhöfer, Vienna/AT09:30 Imaging biomarkers in gastrointestinal oncology E. Neri, Pisa/IT09:50 Interactive case discussions All speakers session 5

10:10 30-minute coffee break

SESSION 6

Hepatobiliary and Pancreatic OncologyChairs: D. Regge, Turin/IT

J. Ricke, Munich/DE

10:40 How imaging helps us in planning biliary and hepatic surgery

D. Tamandl, Vienna/AT11:00 Liver metastases: Detection and treatment response

evaluation D. Regge, Turin/IT11:20 Biliary tumours: Malignant lesions D. Tamandl, Vienna/AT11:40 Interactive case discussions All speakers session 6

12:00 90-minute lunch break

F R IJUNE 29, 2018

SPECIAL SESSION

Immune TherapyChairs: M. D‘Anastasi, Msida/MT

M. Mayerhöfer, Vienna/AT

13:30 Development and current indications of immune therapy M. von Bergwelt, Munich/DE14:00 Assessing response to immune therapy on imaging M. Mayerhöfer, Vienna/AT14:20 Complications of immune therapy: What the radiologist

should be aware of D. Regge, Turin/IT14:40 Interactive case discussions All speakers special session

14:50 20-minute coffee break

SESSION 7

MSK OncologyChairs: D. Panicek, New York/US

M. F. Reiser, Munich/DE

15:20 Calcified soft tissue tumours: Differential diagnosis A. Baur-Melnyk, Munich/DE

15:40 Post-treatment MRI of soft tissue tumours: What do the oncologist and surgeon want to know?

D. Panicek, New York/US16:00 Vertebral fractures: Neoplastic or benign? A. Baur-Melnyk, Munich/DE16:20 Interactive case discussions All speakers session 7

WORKSHOP 2

Response Patterns and Pitfalls associated with Immunotherapy16:45 C. Cyran, Munich/DE

W. Kunz, Munich/DE

WORKSHOP 3 – HANDS-ON

Virtual Colonoscopy – An Introduction for Beginners16:45 A. Laghi, Rome/IT

E. Neri, Pisa/IT

PROGRAMME

S A TJUNE 30, 2018PROGRAMME

BREAST SESSION 1

Breast Imaging Chairs: Th. Helbich, Vienna/AT

E. Morris, New York/US

08:30 Breast imaging with mammogram, US & MRI: When & how?

Th. Helbich, Vienna/AT08:50 Multiparametric US – more style than substance? P. Baltzer, Vienna/AT09:10 Preoperative evaluation using mammography, US & MRI K. Pinker-Domenig, Vienna/AT09:30 Screening with new modalities: DBT and CEDM M. Jochelson, New York/US09:50 What will be the future of screening for breast cancer? E. Morris, New York/US

10:10 30-minute coffee break

BREAST SESSION 2

Breast Imaging Chairs: Th. Helbich, Vienna/AT

E. Morris, New York/US

10:40 Computer assisted approaches – the future? P. Baltzer, Vienna/AT11:00 Evaluating treatment response: MRI and PET M. Jochelson, New York/US11:20 High risk lesions: What is new? B. Brkljačić, Zagreb/HR11:40 Percutaneous ablation: A way to do less? M. Fuchsjäger, Graz/AT

12:00 90-minute lunch break

S A TJUNE 30, 2018PROGRAMME

WORKSHOP 4

Breast Imaging: Challenging Cases13:30 B. Brkljačić, Zagreb/HR

K. Pinker-Domenig, Vienna/AT

WORKSHOP 5

Pelvic MRI: Meet the Experts13:30 M. Gollub, New York/US

H. Hricak, New York/USD. Regge, Turin/IT

WORKSHOP 6

Breast Imaging: Challenging Cases14:30 B. Brkljačić, Zagreb/HR

C. Comstock, New York/US

WORKSHOP 7

Thoracic Imaging: Challenging Cases14:30 M. Ginsberg, New York/US